Anti-inflammatory effects of GLP-1 receptor activation in the brain in neurodegenerative diseases
UNIVERSAL IDENTIFIER: http://hdl.handle.net/11093/3787
EDITED VERSION: https://www.mdpi.com/1422-0067/23/17/9583
DOCUMENT TYPE: article
The glucagon-like peptide-1 (GLP-1) is a pleiotropic hormone well known for its incretin effect in the glucose-dependent stimulation of insulin secretion. However, GLP-1 is also produced in the brain and displays a critical role in neuroprotection and inflammation by activating the GLP-1 receptor signaling pathways. Several studies in vivo and in vitro using preclinical models of neurodegenerative diseases show that GLP-1R activation has anti-inflammatory properties. This review explores the molecular mechanistic action of GLP-1 RAS in relation to inflammation in the brain. These findings update our knowledge of the potential benefits of GLP-1RAS actions in reducing the inflammatory response. These molecules emerge as a potential therapeutic tool in treating neurodegenerative diseases and neuroinflammatory pathologies.
Files in this item
- DizChaves_Yolanda_2022_Ant_inf ...